Small molecule modulation of organelle membrane contact sites

Organelle membrane contact sites (MCSs) regulate calcium exchange, lipid transfer, metabolism, and cellular stress responses. Dysregulation of MCSs contributes to diverse diseases, yet pharmacological strategies that directly modulate contact architecture remain limited. Recent advances in chemoproteomics and live-cell imaging demonstrate that small molecules can remodel organelle contacts by modulating the conformational states of tethering proteins, coordinating associated effector and regulatory assemblies, and reshaping organelle networks. Here, we propose a pharmacological framework that classifies MCS modulators as stabilizers or destabilizers and review representative compounds, highlighting their molecular mechanisms and emerging therapeutic candidates. We further discuss advanced technologies for visualizing MCS dynamics and identifying small molecule-induced proteoforms. This review positions MCSs as actionable drug targets and outlines future directions for organelle-focused pharmacology.